Asston Pharmaceuticals Ltd vs Curis Lifesciences Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 04, 2026

Key Highlights

The Latest Trading Price of Asston Pharmaceuticals Ltd is ₹ 80.9 as of 30 Apr 15:30 . The P/E Ratio of Asston Pharmaceuticals Ltd changed from 0 on March 2022 to 0 on March 2025 . This represents a CAGR of 0.0% over 4 yearsThe P/E Ratio of Curis Lifesciences Ltd changed from 0 on March 2022 to 0 on March 2025 . This represents a CAGR of 0.0% over 4 years The Market Cap of Asston Pharmaceuticals Ltd changed from ₹ 0 crore on March 2022 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 4 yearsThe Market Cap of Curis Lifesciences Ltd changed from ₹ 0 crore on March 2022 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 4 years The Revenue of Asston Pharmaceuticals Ltd is ₹ 0 crore as of Jun '24 .The Revenue of Curis Lifesciences Ltd is ₹ 9.12 crore as of Jun '24 . The EBITDA of Asston Pharmaceuticals Ltd is ₹ 0 crore as of Jun '24 .The EBITDA of Curis Lifesciences Ltd is ₹ 2.73 crore as of Jun '24 . The Net Profit of Asston Pharmaceuticals Ltd is ₹ 0 crore as of Jun '24 .The Net Profit of Curis Lifesciences Ltd is ₹ 1.2 crore as of Jun '24 . The Dividend Payout of Asston Pharmaceuticals Ltd changed from 0 % on March 2022 to 0 % on March 2025 . This represents a CAGR of 0.0% over 4 yearsThe Dividend Payout of Curis Lifesciences Ltd changed from 0 % on March 2022 to 0 % on March 2025 . This represents a CAGR of 0.0% over 4 years .

About Asston Pharmaceuticals Ltd

Asston Pharmaceuticals Limited was incorporated on 16th April 2019 as 'Asston Pharmaceutical Pvt.
Limited' to contract produce pharmaceutical products for export market.
Later on 1st April 2024, Company acquired Ferron Lifecare Private Limited, specializing into nutraceuticals business and produced nutraceutical products at their Ambarnath facility.
Ferron Lifecare Private Limited, incorporated on 30th January 2020.
Finally, 'Asston Pharmaceuticals Private Limited' was converted into a Public Limited Company in the name of 'Asston Pharmaceuticals Limited' on 29th August 2024 and received FDA approval for its Ambarnath facility on 2nd December 2024 to produce pharmaceutical products. Presently, Company is involved in the business of manufacturing and marketing of Tablets, Capsules, Oral Liquid, External Preparations (Ointment, Cream, Gel and Lotion) and Oral Powder (Sachet, Dry Syrup) etc.

About Curis Lifesciences Ltd

Curis Lifesciences Limited was originally formed and registered as a Partnership Firm under the Partnership Act, 1932 in the name and style of 'M/s Loreto Pharmaceutacals', pursuant to a Deed of Partnership dated 2 June, 2010.
Thereafter ' M/s Loreto Pharmaceutacals' was converted from Partnership Firm to a Private Limited Company as 'Curis Lifesciences Private Limited' and received a Certificate of Incorporation dated on March 23rd, 2016 issued by Registrar of Companies, Ahmedabad.
Subsequently, Company was converted into a Public Limited Company and the name of the Company was changed from 'Curis Lifesciences Private Limited' to 'Curis Lifesciences Limited' vide certified incorporated upon the conversion dated August 9, 2024, issued by the Central Processing Centre, Manesar. Company's business is related to manufacturing of pharmaceutical products for different markets globally as well as domestic.

FAQs for the comparison of Asston Pharmaceuticals Ltd and Curis Lifesciences Ltd

Which company has a larger market capitalization, Asston Pharmaceuticals Ltd or Curis Lifesciences Ltd?

Market cap of Asston Pharmaceuticals Ltd is 68 Cr while Market cap of Curis Lifesciences Ltd is 100 Cr

What are the key factors driving the stock performance of Asston Pharmaceuticals Ltd and Curis Lifesciences Ltd?

The stock performance of Asston Pharmaceuticals Ltd and Curis Lifesciences Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Asston Pharmaceuticals Ltd and Curis Lifesciences Ltd?

As of May 4, 2026, the Asston Pharmaceuticals Ltd stock price is INR ₹80.9. On the other hand, Curis Lifesciences Ltd stock price is INR ₹124.9.

How do dividend payouts of Asston Pharmaceuticals Ltd and Curis Lifesciences Ltd compare?

To compare the dividend payouts of Asston Pharmaceuticals Ltd and Curis Lifesciences Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.